openPR Logo
Press release

What's driving the Rheumatoid Arthritis Market Size? Prominent Players are Sanofi, Pfizer, Johnson & Johnson, AbbVie, GE Healthcare, Amgen

06-27-2019 03:56 PM CET | Health & Medicine

Press release from: persistencemarketresearch.com

What's driving the Rheumatoid Arthritis Market Size? Prominent

Arthritis is a problem associated with joints, in which a person suffers from red, hot, swollen and functionally impaired joints. Rheumatoid arthritis is a type of arthritis that is caused due to loss of tissue lining. A new research report by Persistence Market Research focuses on the various treatment options for rheumatoid arthritis and presents a forecast for this market for next few years. The report is titled ‘Rheumatoid Arthritis Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’ and reveals the findings of this exhaustive research program. According to the report insights, the global rheumatoid arthritis market held a market value of over US$ 23,900 Mn in 2017, which is expected to reach a valuation in excess of US$ 37,800 Mn by the end of 2025, growing at a CAGR of 5.9%.

Get Sample Copy of This Report@ https://www.persistencemarketresearch.com/samples/22555

This research report comprises a detailed presentation of all the companies leading in the global market. These companies are considered to hold a higher customer base than any other companies in the industry. The drugs manufactured by these companies are widely used in the global market and there are several other products in the pipeline. Some of these companies mentioned in the report are Sanofi SA, Pfizer Inc., Hoffman-La Roche AG, Johnson & Johnson, AbbVie Inc., Eli Lilly & Company, Amgen Inc. and Sobi Inc.

The growth of the rheumatoid arthritis market is driven by macro-economic factors like the increase in aging population of many countries, which subsequently increases the number of patients suffering from rheumatoid arthritis. The prevalence of this disease is also seen to be high in women; one in every 12 women develops rheumatoid arthritis during her lifetime. There is also a rise in awareness about the disease in many developed regions. This has increased the rate of disease treatment rather than symptoms treatment. As people are more aware about rheumatoid arthritis they get more inclined towards treating the disease, thereby boosting the sales of drugs in the rheumatoid arthritis treatment market. These factors are expected to mark the advent of a bunch of new products that will hit the market within the next eight years.

The North America rheumatoid arthritis market held the highest market value in the past and is also expected to continue leading the global market in future, with a market value of over US$ 16,000 Mn estimated by the end of 2025. However, Asia Pacific is an emerging leader in the competition and is expected to grow at the highest rate of 7.9% during the forecast period 2017-2025. Middle East and Africa is also expected to show huge scope for development in the global market.
Rheumatoid arthritis is one of the leading causes of disability in the Middle East and Africa. A study reveals that prevalence of the disease is reported to be at 0.3% in Egypt and 0.4% in Lesotho. Considering the poor yet fastest growing economy of Africa, generic players have massive scope for growth in the region.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/22555

However there are a few factors that may lead to instability for these businesses, like the discontinuation of drugs due to side effects and associated limitations. It is yet to be seen whether the leading players will come up with a product line that overcomes such challenges and drive the growth of the global rheumatoid arthritis treatment market.

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Global Rheumatoid Arthritis Treatments Market View Point
3.1. Market Dynamics
3.1.1. Macro-Economic Factors
3.1.2. Drivers
3.1.3. Restraints

3.1.4. Opportunity Analysis
3.1.5. Recent Trends
3.2. Epidemiology of Rheumatoid Arthritis
3.3. Pipeline Assessment
3.4. Regenerative Therapy: A Hope for RA Patients

4. North America Rheumatoid Arthritis Treatment Market Analysis 2012–2016 and Forecast 2017–2025
4.1. Introduction
4.2. Historical Market Size (US$ Mn) and Analysis By Country, 2012–2016
4.2.1. U.S.
4.2.2. Canada

4.3. Market Size (US$ Mn) and Forecast By Country, 2017–2025
4.3.1. U.S.
4.3.2. Canada
4.4. Historical Market Size (US$ Mn) and Analysis By Treatment, 2012–2016
4.4.1. Symptomatic Treatment

4.4.2. Intermediate Corticosteroid Therapies
4.4.3. Disease Modifying Anti-rheumatic Drug (DMARD) Therapies
4.4.3.1. Conventional DMARD
4.4.3.2. Biologic DMARD
4.5. Market Size (US$ Mn) and Forecast By Treatment, 2017–2025
4.5.1. Symptomatic Treatment
4.5.2. Intermediate Corticosteroid Therapies

4.5.3. Disease Modifying Anti-rheumatic Drug (DMARD) Therapies
4.5.3.1. Conventional DMARD
4.5.3.2. Biologic DMARD
4.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
4.6.1. Hospital Pharmacies
4.6.2. Retail Pharmacies
4.6.3. Drugstores

4.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
4.7.1. Hospital Pharmacies
4.7.2. Retail Pharmacies
4.7.3. Drugstores
4.8. Market Attractiveness Analysis
4.8.1. By Country
4.8.2. By Treatment
4.8.3. By Distribution Channel

Full Report@ https://www.persistencemarketresearch.com/market-research/rheumatoid-arthritis-treatment-market.asp

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Rheumatoid Arthritis Market Size? Prominent Players are Sanofi, Pfizer, Johnson & Johnson, AbbVie, GE Healthcare, Amgen here

News-ID: 1790537 • Views:

More Releases from persistencemarketresearch.com

Innovation-Based Discernment To Drive The Foil Shavers Market
Innovation-Based Discernment To Drive The Foil Shavers Market
Personal appearance has taken paramount importance in the lives of consumers. Proper grooming and professional appearance have become important attributes to gain respect at the workplace. The way people carry themselves creates an impression on co-workers and the management. The pressure and interest of looking good is equally important to both, men and women. Variations offered by trimmers and shavers have taken up the onus to drive the foil shavers
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Growth According to 'Persistence Market Research'
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are Haw Par Corporation Limited., Procter & Gamble, GSK group of companies, Amrutanjan Health Care Ltd. and others. The companies are mainly focusing on intense marketing to conve
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia

All 5 Releases


More Releases for Rheumatoid

How To Cure Rheumatoid Arthritis 2021 ?
Grocare® launches new kit to manage Rheumatoid Arthritis - New findings support research-based kit for management of Rheumatoid Arthritis Pune, May 13, 2021: Pune-based Grocare® has recently launched an advanced research-based kit that alleviates and controls Rheumatoid Arthritis, conditions. This kit contains Absogen®, GC® and Acidim® designed to correct mitochondrial imbalance, build immunity and balance PH, respectively. Grocare® is a pharmaceutical company that has conducted extensive research on Rheumatoid Arthritis. The company’s data
Major Advancements| Competitor Landscape: Rheumatoid Arthritis
Researchmoz added Most up-to-date research on "Competitor Landscape: Rheumatoid Arthritis" to its huge collection of research reports. Competitor Landscape: Rheumatoid Arthritis Summary Sociable Pharmas Treatment Landscape contains evaluations of ongoing development activities within the Rheumatoid Arthritis (RA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher - - Executive Summary: Contains analysis of key market events that have occurred during
Global Rheumatoid Arthritis Drugs Market | MarketResearchReports.biz
Latest industry research report on: Global Rheumatoid Arthritis Drugs Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts The Rheumatoid Arthritis Drugs Market has been comprehensively detailed in the report with special focus on a range of key elements such as market share, forecast and base figures, CAGR, driving factors, growth restraints, and business opportunities. Buyers of the report are expected to be informed about significant
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards Rheumatoid Arthritis 1.2 Obtainable Treatment for Rheumatoid Arthritis Molecular Mechanism of Antirheumatoids 2.1 Purpose of DMARDs in Rheumatoid Arthritis 2.2 Role of Biological Agents in Rheumatoid Arthritis 2.2.1 TNF- Inhibitors 2.2.2 Interleukin -1 and IL-6 Blockers Classification of Rheumatoid Arthritis Drugs 3.1
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the